Or Refractory B-cell Acute Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-01-16
Clinical Trial Update: Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia [Phase 2]
This clinical trial update reports the termination of a Phase 2 study of ibrutinib in adults with relapsed or refractory B-cell acute lympho…